There are many literature reports on MM-bone disease, describing the up-regulation of RANKL in association with different mechanisms involving both cells of the osteoblastic lineage (34) and immune cells, such as T lymphocytes (12, 33, 35). This evidence concerns the gene TNFSF11 and Miyoshi myopathy.